The Key Distinction is Dose Rybelsus maxes out at 14 mg dailyenough for glycemic control, but the weight loss at that dose is modest (typically 3-4%)
Regardless of the format, the BUD provided by the pharmacy remains the ultimate authority on when to stop using the product
Clinical evidence shows that weight regain is common after stopping these injections, with studies indicating patients may regain approximately two-thirds of lost weight within one year of discontinuation
This may make your treatment with Ozempic harder, no matter the dose
Meanwhile, GLP-1RAs showed a trend towards a reduced risk for nine respiratory diseases, although not reaching statistical significance, including pneumonia (RR 0.89, 95% CI 0.781.00, p = 0.05